Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Anchiano Therapeutics Ltd ADR (ANCN)

Anchiano Therapeutics Ltd ADR (ANCN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 34,948
  • Shares Outstanding, K 7,420
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,610 K
  • 60-Month Beta 0.95
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.77
Trade ANCN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.46
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/06/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.41
  • Growth Rate Est. (year over year) +243,758.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.60 +81.15%
on 03/04/21
8.20 -42.56%
on 03/16/21
-0.18 (-3.68%)
since 02/16/21
3-Month
1.65 +185.45%
on 01/04/21
10.55 -55.36%
on 02/10/21
+2.09 (+79.77%)
since 12/16/20
52-Week
0.51 +817.06%
on 03/20/20
10.55 -55.36%
on 02/10/21
+4.06 (+622.84%)
since 03/16/20

Most Recent Stories

More News
SHAREHOLDER ALERT: WeissLaw LLP Reminds CNIG, CHNG, CATM, and ANCN Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

CNIG : 23.6900 (+1.24%)
CHNG : 22.97 (+0.66%)
CATM : 38.83 (+0.08%)
ANCN : 4.71 (+5.37%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds CNIG, CHNG, CATM, and ANCN Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

CNIG : 23.6900 (+1.24%)
CHNG : 22.97 (+0.66%)
CATM : 38.83 (+0.08%)
ANCN : 4.71 (+5.37%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds CHNG, CPAH, CATM, and ANCN Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

CHNG : 22.97 (+0.66%)
CPAH : 3.48 (+0.58%)
CATM : 38.83 (+0.08%)
ANCN : 4.71 (+5.37%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds CPAH, CATM, ANCN and GNBF Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

CPAH : 3.48 (+0.58%)
CATM : 38.83 (+0.08%)
ANCN : 4.71 (+5.37%)
GNBF : 84.0000 (+1.14%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds CPAH, CATM, ANCN and GNBF Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

CPAH : 3.48 (+0.58%)
CATM : 38.83 (+0.08%)
ANCN : 4.71 (+5.37%)
GNBF : 84.0000 (+1.14%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of INFO, PS, CATM, and ANCN Mergers

Rigrodsky Law, P.A. announces that it is investigating:

INFO : 104.04 (+0.52%)
PS : 22.45 (+0.13%)
CATM : 38.83 (+0.08%)
ANCN : 4.71 (+5.37%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds CHNG, CPAH, CATM, and ANCN Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

CHNG : 22.97 (+0.66%)
CPAH : 3.48 (+0.58%)
CATM : 38.83 (+0.08%)
ANCN : 4.71 (+5.37%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Anchiano Therapeutics Ltd. - ANCN

, /PRNewswire/ -- , founder and managing partner at , a national securities firm headquartered at the in , is investigating Anchiano Therapeutics Ltd. ("ANCN" or the "Company") () relating to its proposed...

ANCN : 4.71 (+5.37%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, WORK, and GNBF Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

ANCN : 4.71 (+5.37%)
PRVL : 23.00 (-0.09%)
WORK : 42.12 (-0.43%)
GNBF : 84.0000 (+1.14%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, TLRY, and GNBF Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

ANCN : 4.71 (+5.37%)
PRVL : 23.00 (-0.09%)
TLRY : 15.97 (-8.43%)
GNBF : 84.0000 (+1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company. It focuses on the discovery and development of novel therapies to treat cancer. The company's product candidate, inodiftagene vixteplasmid, is in development as a treatment for non-muscle-invasive bladder cancer. It operates primarily...

See More

Key Turning Points

3rd Resistance Point 10.67
2nd Resistance Point 9.44
1st Resistance Point 7.07
Last Price 4.71
1st Support Level 3.47
2nd Support Level 2.24
3rd Support Level N/A

See More

52-Week High 10.55
Fibonacci 61.8% 6.72
Fibonacci 50% 5.53
Last Price 4.71
Fibonacci 38.2% 4.35
52-Week Low 0.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar